You are here:

NICE
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers

Bortezomib monotherapy for relapsed multiple myeloma

Technology appraisal guidance
Reference number: TA129
Published: 23 October 2007

Guidance
Tools and resources
Information for the public
History

Appendix A: GE decision paper

Appendix A: GE decision paper

Appendix A: GE decision paper
13 November 2012
(74.29 Kb 21 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 12 November 2012